Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 15.6

Steroid Avoidance Rate at Discharge, 2000 to 2009

Recipients of Heart Transplants

Discharge Regimen Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total Patients 1,909 1,914 1,905 1,817 1,780 1,847 1,918 1,963 1,954 1,980
Steroids Avoided 102 54 56 134 140 120 150 218 244 223
Rate 5.3% 2.8% 2.9% 7.4% 7.9% 6.5% 7.8% 11.1% 12.5% 11.3%
CyA Patients 89 37 47 34 13 14 27 19 12 16
Steroids Avoided 13 6 1 2 2 2 3 1 1 3
Rate 14.6% 16.2% 2.1% 5.9% 15.4% 14.3% 11.1% 5.3% 8.3% 18.8%
Tac Patients 41 68 75 60 38 44 46 58 64 94
Steroids Avoided 2 5 2 7 3 7 11 13 21 27
Rate 4.9% 7.4% 2.7% 11.7% 7.9% 15.9% 23.9% 22.4% 32.8% 28.7%
CyA+MMF Patients 1,078 1,011 825 805 739 615 595 525 410 312
Steroids Avoided 37 18 15 37 34 30 36 47 38 22
Rate 3.4% 1.8% 1.8% 4.6% 4.6% 4.9% 6.1% 9.0% 9.3% 7.1%
Tac+MMF Patients 161 371 460 540 689 892 1,000 1,174 1,301 1,405
Steroids Avoided 5 7 16 48 47 48 71 137 165 153
Rate 3.1% 1.9% 3.5% 8.9% 6.8% 5.4% 7.1% 11.7% 12.7% 10.9%
CyA+Aza Patients 301 204 136 92 83 48 42 29 15 16
Steroids Avoided 21 9 11 10 14 7 3 3 4 3
Rate 7.0% 4.4% 8.1% 10.9% 16.9% 14.6% 7.1% 10.3% 26.7% 18.8%
Tac+Aza Patients 39 25 25 24 22 20 26 20 27 40
Steroids Avoided 1 1 2 2 4 4 1 4 1 4
Rate 2.6% 4.0% 8.0% 8.3% 18.2% 20.0% 3.8% 20.0% 3.7% 10.0%
CyA+Siro Patients 12 3 18 38 2 1 2 - 2 -
Steroids Avoided 1 0 1 1 0 0 0 - 0 -
Rate 8.3% 0.0% 5.6% 2.6% 0.0% 0.0% 0.0% - 0.0% -
Tac+Siro Patients 17 39 108 32 15 21 19 6 5 7
Steroids Avoided 0 0 3 1 2 6 8 5 5 2
Rate 0.0% 0.0% 2.8% 3.1% 13.3% 28.6% 42.1% 83.3% 100.0% 28.6%
Siro+MMF Patients - 4 7 18 19 16 22 5 4 10
Steroids Avoided - 0 0 1 2 1 1 0 0 0
Rate - 0.0% 0.0% 5.6% 10.5% 6.3% 4.5% 0.0% 0.0% 0.0%
Other Regimen Patients 171 152 204 174 160 176 139 127 114 80
Steroids Avoided 22 8 5 25 32 15 16 8 9 9
Rate 12.9% 5.3% 2.5% 14.4% 20.0% 8.5% 11.5% 6.3% 7.9% 11.3%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressive

drug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;

Siro: Sirolimus.